AI-generated summary
The authors used three-dimensional cultured HEK 293 APPsw cells as an Alzheimer's disease model and label-free nonlinear optical imaging to track beta-amyloid aggregation. They report that near-infrared light from an 808 nm laser, compared with 1064, 1210 and 1470 nm lasers, was associated with reduced plaque formation in a dose-dependent manner, along with increased LRP1 receptor expression. The study was conducted in cultured cells, not in people.
- Who or what was studied
- 3D cultured HEK 293 APPsw cells used as an Alzheimer's disease model
- Wavelengths
- 808, 1064, 1210, 1470 nm
- Limits stated in the abstract
- The study used cultured cells rather than humans or animals, so the findings may not apply to living brains.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on opg.optica.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 1470 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Near-infrared, Photon, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.